The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks start week higher as 2024 draws to close

Wed, 27th Dec 2023 17:02

(Alliance News) - Equities in London kicked off an abbreviated trading week with gains on Wednesday, on continued US interest rate optimism at the end of 2024.

The FTSE 100 index ended up 27.44 points, 0.4%, at 7,724.95. The FTSE 250 closed up 89.80 points, 0.5%, at 19,720.75, and the AIM All-Share rose 8.63 points, 1.1%, at 763.03.

The Cboe UK 100 closed up 0.3% at 771.49, the Cboe UK 250 ended up 0.5% at 17,202.29, and the Cboe Small Companies rose 0.6% to 14,813.98.

"Last year started amid a cloud of pessimism that turned out too extreme. Stocks rose smartly as a result. This year, we set the stage for 2024 amid growing optimism with inflation receding and profit forecasts rising," Tower Bridge Advisors analysts commented.

The CAC 40 in Paris closed marginally higher, while the DAX 40 in Frankfurt added 0.2%.

The Bureau of Economic Analysis on Friday said the core personal consumption expenditures price index rose annually by 3.2% in November, slowing from 3.4% in October, which was first reported at 3.5%. The latest figure was just below the FXStreet-cited market consensus of 3.3%.

The core reading, the Fed's preferred inflation gauge, does not include food or energy. It has been slowing steadily in recent months. It stood at 4.2% in July, cooling to 3.7% in August and 3.6% in September.

The headline PCE index rose 2.6% year-on-year last month, cooling from October's annual rise of 2.9%, which was first reported at 3.0%, and September's 3.4% rise.

The cooler inflation prints solidified market betting on US interest rate cuts.

Brown Brothers Harriman analysts commented: "Six cuts are fully priced in by end-2024. While we still strongly disagree with this market pricing, it will now take a much longer string of stronger data to shift the narrative than what was needed before the Fed's dovish hold."

The Fed has enacted three successive pauses. Equipment rental firm Ashtead Group, exposed to the ebbs and flows of the US economy, rose 1.2% in London, on hope that the Fed will soon start cutting rates.

Stocks in New York were mixed, but had kicked off the holiday-shortened week positively on Tuesday. The Dow Jones Industrial Average was up 0.1% at the time of the European equities close, the S&P 500 was flat and the Nasdaq Composite was down 0.1%.

CPT Markets analyst Vikas Lakhwani commented: "The market remains on a strong uptrend since the end of October thanks to an optimistic sentiment. All major indices rose, with the Nasdaq and the S&P 500 reaching toward new highs. Despite the low volumes typical of the holiday season, performance remained positive overall. At the same time, market expectations of early rate cuts in March could continue to boost sentiment and performances on the market."

Sterling was quoted at USD1.2797 late Wednesday afternoon in London, higher than USD1.2719 at the early London equities close on Friday. The euro traded at USD1.1115, up from USD1.1019. Against the yen, the dollar was quoted at JPY141.88, down versus JPY142.14.

UK Chancellor of the Exchequer Jeremy Hunt on Wednesday announced a spring budget will be set out on March 6, in what could be his last chance to introduce tax changes before the next general election.

Hunt has commissioned the Office for Budget Responsibility to prepare an economic and fiscal forecast to be presented to Parliament alongside the budget next year.

The Tories have been dropping hints they could make attention-grabbing pledges on housing and taxes as UK Prime Minister Rishi Sunak struggles to turn around his party's major deficit in the polls.

Housing Secretary Michael Gove suggested to the Times that the Conservatives will promise to cut the up-front cost of a home for first-time buyers in a pre-election giveaway.

Back in London, Anglo American rose 2.3%, its fifth successive daily gain and seventh in the previous eight trading days. Shares in the miner are still down some 10% since December 7, the day it announced an underwhelming outlook.

Next lost 0.9%, Frasers fell 0.8% and B&M gave back 1.2% as bricks and mortar retailers struggled despite some "encouraging" Boxing Day footfall data.

MRI Software said footfall was 4% higher on-year during the busy shopping day. However, it was down 15% from pre-virus levels amid "the continued impact of the rise of online shopping, the close proximity of Black Friday deterring further spend and the potential restrictions of the cost of living crisis".

Online-only electricals retailer AO World climbed 2.1%.

Elsewhere, AstraZeneca added 0.9%.

Astra announced on Tuesday it has agreed to buy Nasdaq-listed Gracell Biotechnologies and will pay about USD1.2 billion for the clinical-stage company. The Cambridge, England-based pharmaceutical company said it expects the acquisition to close in the first quarter of 2024.

Gracell is a Suzhou, China-based biopharmaceutical firm developing cell therapies for cancer and autoimmune diseases. AstraZeneca will pay USD2.00 per share, or USD10.00 per American depositary share, for Gracell at closing, plus USD0.30 per share "upon achievement of a specified regulatory milestone".

The upfront cash portion represents a transaction value of around USD1.0 billion, with the total value being about USD1.2 billion if the milestone is achieved. Gracell ADSs closed up 60% at USD9.92 in New York on Tuesday.

On AIM, shares in Horizonte Minerals surged 67%.

The London-based nickel development company celebrated securing a USD20 million funding package "that will allow for critical construction streams to advance at its flagship Araguaia nickel project" in Brazil, and serve as working capital.

WH Ireland shot up 20%. The stockbroker and wealth manager reported a weaker period for six months that ended September 30, with a sharp drop in revenue and a widened pretax loss. CEO Phillip Wale said this reflected the "well documented challenging market backdrop", in addition to non-recurring costs associated with its refinancing over the summer.

However, market conditions have shown "some tentative signs of improvement" since November, he added, which has enabled WH Ireland to undertake some its largest fundraising in many months across public and private markets. The business delivered underlying monthly profitability in November, he noted.

Gold was quoted at USD2,080.29 an ounce late Wednesday in London, higher than USD2,055.55 shortly after midday in London on Friday. Brent oil was trading at USD80.15 a barrel, up slightly from USD80.02.

Thursday's economic calendar has retail sales and industrial production data from Japan overnight. There is the latest US jobless claims data at 1330 GMT.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
Today 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
Today 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
Today 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.